Annual Non Current Assets
$24.53 M
-$4.02 M-14.07%
31 December 2023
Summary:
Black Diamond Therapeutics annual long term assets is currently $24.53 million, with the most recent change of -$4.02 million (-14.07%) on 31 December 2023. During the last 3 years, it has risen by +$14.42 million (+142.52%). BDTX annual non current assets is now -23.28% below its all-time high of $31.98 million, reached on 31 December 2021.BDTX Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Non Current Assets
$22.36 M
-$874.00 K-3.76%
30 September 2024
Summary:
Black Diamond Therapeutics quarterly long term assets is currently $22.36 million, with the most recent change of -$874.00 thousand (-3.76%) on 30 September 2024. Over the past year, it has dropped by -$2.98 million (-11.74%). BDTX quarterly non current assets is now -84.17% below its all-time high of $141.21 million, reached on 30 June 2020.BDTX Quarterly Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BDTX Non Current Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -14.1% | -11.7% |
| 3 y3 years | +142.5% | -31.4% |
| 5 y5 years | +10000.0% | +1155.4% |
BDTX Non Current Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -23.3% | +142.5% | -31.4% | at low |
| 5 y | 5 years | -23.3% | >+9999.0% | -84.2% | +3018.3% |
| alltime | all time | -23.3% | >+9999.0% | -84.2% | >+9999.0% |
Black Diamond Therapeutics Non Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $22.36 M(-3.8%) |
| June 2024 | - | $23.23 M(-2.0%) |
| Mar 2024 | - | $23.71 M(-3.3%) |
| Dec 2023 | $134.03 M(+5.0%) | $24.53 M(-3.2%) |
| Sept 2023 | - | $25.33 M(-5.8%) |
| June 2023 | - | $26.89 M(-2.6%) |
| Mar 2023 | - | $27.61 M(-3.3%) |
| Dec 2022 | $127.71 M(-40.8%) | $28.55 M(-3.0%) |
| Sept 2022 | - | $29.44 M(-2.8%) |
| June 2022 | - | $30.28 M(-2.9%) |
| Mar 2022 | - | $31.18 M(-2.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | $215.70 M(-32.5%) | $31.98 M(-1.8%) |
| Sept 2021 | - | $32.58 M(+92.4%) |
| June 2021 | - | $16.93 M(+6.4%) |
| Mar 2021 | - | $15.91 M(+57.3%) |
| Dec 2020 | $319.55 M(+105.2%) | $10.12 M(+1.1%) |
| Sept 2020 | - | $10.01 M(-92.9%) |
| June 2020 | - | $141.21 M(>+9900.0%) |
| Mar 2020 | - | $717.00 K(-72.2%) |
| Dec 2019 | $155.71 M(+201.3%) | $2.58 M(+44.9%) |
| Sept 2019 | - | $1.78 M(+1154.2%) |
| Dec 2018 | $51.68 M(+553.1%) | $142.00 K |
| Dec 2017 | $7.91 M | - |
FAQ
- What is Black Diamond Therapeutics annual long term assets?
- What is the all time high annual non current assets for Black Diamond Therapeutics?
- What is Black Diamond Therapeutics annual non current assets year-on-year change?
- What is Black Diamond Therapeutics quarterly long term assets?
- What is the all time high quarterly non current assets for Black Diamond Therapeutics?
- What is Black Diamond Therapeutics quarterly non current assets year-on-year change?
What is Black Diamond Therapeutics annual long term assets?
The current annual non current assets of BDTX is $24.53 M
What is the all time high annual non current assets for Black Diamond Therapeutics?
Black Diamond Therapeutics all-time high annual long term assets is $31.98 M
What is Black Diamond Therapeutics annual non current assets year-on-year change?
Over the past year, BDTX annual long term assets has changed by -$4.02 M (-14.07%)
What is Black Diamond Therapeutics quarterly long term assets?
The current quarterly non current assets of BDTX is $22.36 M
What is the all time high quarterly non current assets for Black Diamond Therapeutics?
Black Diamond Therapeutics all-time high quarterly long term assets is $141.21 M
What is Black Diamond Therapeutics quarterly non current assets year-on-year change?
Over the past year, BDTX quarterly long term assets has changed by -$2.98 M (-11.74%)